Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Cell Therapy Market, By Use-type
7.1. Cell Therapy Market, By Use-type Type, 2020-2030
7.1.1. Clinical-use
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Research-use
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Cell Therapy Market, By Therapy Type
8.1. Cell Therapy Market, By Therapy Type, 2020-2030
8.1.1. Allogenic Therapies
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Autologous Therapies
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Cell Therapy Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.1.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.1.3.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.1.4.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.2.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.2.3.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.2.4.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.2.5.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.2.6.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.3.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.3.3.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.3.4.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.3.5.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.3.6.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.4.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.4.3.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.4.4.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.4.5.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.4.6.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.5.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.5.3.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, By Use-type (2016-2030)
9.5.4.2. Market Revenue and Forecast, By Therapy Type (2016-2030)
Chapter 10. Company Profiles
10.1. Kolon TissueGene, Inc.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Anterogen Co., Ltd.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. JCR Pharmaceuticals Co., Ltd.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Castle Creek Biosciences, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. The Future of Biotechnology, MEDIPOST
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Osiris Therapeutics, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. PHARMICELL Co., Ltd
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Tameika Cell Technologies, Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Cells for Cells
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. NuVasive, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.11. Vericel Corporation
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.12. Celgene Corporation
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Tracheostomy Products Market (By Demographics: Adults, Paediatrics/Neonatal; By Type: Tracheostomy Tubes, Ventilation Accessories ; By Technique; By End Use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.
Read more...
Smart Blood Pressure Monitoring Devices Market (By Type: Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor Finger Blood Pressure Monitor; By Technology: Wi-Fi Based/4G, Bluetooth Based)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030
Read more...
Laparoscopic Electrodes Market (By Application: Bariatric, General Surgeries; By Product: Monopolar, Bipolar Electrodes; By End User: Hospital, Ambulatory)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030
Read more...
U.S. Virtual Visits Market (By Service Type: Cold & Flu management, Allergies, Urgent Care, Preventive Care, Chronic Care Management, Behavioural Health ; By Commercial Plan Type: Small Group, Self-Funded/ASO Group Plans, Medicaid, Medicare, By Age Group, By Gender)- Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030
Read more...
Next-Generation Sequencing Services Market (By Service Type: Human Genome Sequencing, Gene Regulation Services; By Workflow: Pre-sequencing, Sequencing, Data Analysis; By End-use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030
Read more...